)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Balaxi Pharmaceuticals
Balaxi Pharmaceuticals (BALAXI) investor relations material
Balaxi Pharmaceuticals Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary5 Aug, 2026
Executive summary
Approved unaudited standalone and consolidated financial results for the quarter ended 30th June 2026.
Commenced commercial production at the new pharmaceutical formulation facility in Jadcherla, Hyderabad, with two initial products and permissions for 29 additional products, expanding the commercial portfolio to 31 products.
WHO-GMP audit conducted at the new facility; CAPA response submitted and certification process underway.
Financial highlights
Consolidated revenue from operations for Q1 FY27 was ₹8,068.18 lakhs, up from ₹7,071.37 lakhs in Q1 FY26.
Consolidated net profit for Q1 FY27 stood at ₹129.74 lakhs, compared to ₹29.01 lakhs in Q1 FY26.
Standalone revenue for Q1 FY27 was ₹1,558.37 lakhs, down from ₹1,670.82 lakhs in Q1 FY26.
Standalone net loss for Q1 FY27 was ₹125.32 lakhs, compared to a net profit of ₹19.49 lakhs in Q1 FY26.
Basic and diluted EPS for the consolidated entity was ₹0.24 for Q1 FY27, up from ₹0.05 in Q1 FY26.
Outlook and guidance
Ongoing expansion of product portfolio and manufacturing operations at the new facility, with further product approvals being pursued.
WHO-GMP certification expected to enhance manufacturing credentials and support future growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Balaxi Pharmaceuticals
- Q2 FY26 revenue fell 27% YoY, gross margin stayed strong, and $4M was approved for Dubai expansion.BALAXI
Q2 25/2619 Jun 2026 - Standalone revenue and profit surged, manufacturing expansion achieved, and audit opinions unmodified.BALAXIQ4 25/2628 May 2026
- Q3 FY26 revenue rose sequentially, margins were pressured, and the new plant is inspection-ready.BALAXIQ3 25/2630 Jan 2026
- Margins improved and profitability returned as a USD 5M Dubai investment supports expansion.BALAXIQ1 24/2520 Nov 2025
- Q2 FY25 revenue surged 41% YoY, but PAT dropped 68% amid margin pressures.BALAXIQ2 24/2520 Nov 2025
- Revenue up 21% year-over-year, net profit more than doubled, new plant validation underway.BALAXIQ4 24/2511 Aug 2025
- Revenue and profit rose year-over-year, with new plant operations to start in September 2025.BALAXIQ1 25/2611 Aug 2025
- Revenue rose but margins fell; Hyderabad plant to boost future growth.BALAXIQ3 20256 Jun 2025
Next Balaxi Pharmaceuticals earnings date
Q2 26/2713 Nov, 2026
Balaxi Pharmaceuticals
Next Balaxi Pharmaceuticals earnings date
Q2 26/2713 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage